GGrantIndex
← Search

A NOVEL ENZYME REPLACEMENT THERAPY FOR ROBUST HYPOXIA TOLERANCE AND MITIGATION OF REPERFUSION INJURY IN VASCULARIZED COMPOSITE ALLOTRANSPLANTION.

$199,958FY2019Defense Health AgencyDOD

Wake Forest University Health Sciences, Winston-Salem NC

Investigators

View source on USAspending →
A NOVEL ENZYME REPLACEMENT THERAPY FOR ROBUST HYPOXIA TOLERANCE AND MITIGATION OF REPERFUSION INJURY IN VASCULARIZED COMPOSITE ALLOTRANSPLANTION. · GrantIndex